Immatics Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Juno Therapeutics.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 29723% increase | Employees 1091% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income (€196.4m) (FY, 2025) | Net income ($437.1m) (FY, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 267.3m | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Juno Therapeutics
HQ
Seattle, US
Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company